ARCT - Arcturus Therapeutics Holdings Inc.
NEXT EARNINGS:
Mar 3, 2026
(in 6 days)
EPS Est: $-0.92
|
Rev Est: $14.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$20.00
LOW:
$20.00
MEDIAN:
$20.00
CONSENSUS:
$20.00
UPSIDE:
144.50%
Market Cap:
232.43M
Volume:
440,234
Avg Volume:
591,488
52 Week Range:
5.85-24.17
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.43
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
174
IPO Date:
2013-05-22
EPS (TTM):
-3.00
P/E Ratio:
-5.66
Revenue (TTM):
138.39M
Total Assets:
344.07M
Total Debt:
28.55M
Cash & Equiv:
237.03M
Rev Growth (5Y):
46.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-29.1%
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.49 | $-0.80 | +38.7% | $17.2M | $16.0M | +7.0% |
| 2025-08-11 | $-0.34 | $-1.11 | +69.4% | $24.5M | $18.3M | +33.6% |
| 2025-05-12 | $-0.52 | $-1.58 | +67.1% | $29.4M | $23.3M | +25.8% |
| 2025-03-06 | $-1.11 | $-0.33 | -236.4% | $21.0M | $44.6M | -53.0% |
| 2024-11-07 | $-0.26 | $-0.70 | +62.9% | $38.8M | $45.9M | -15.5% |
| 2024-08-05 | $-0.64 | $-1.85 | +65.4% | $46.0M | $34.2M | +34.2% |
| 2024-05-08 | $-1.00 | $-1.17 | +14.5% | $32.6M | $17.5M | +85.8% |
| 2024-03-07 | $-0.32 | $-1.69 | +81.1% | $28.2M | $37.9M | -25.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.39M | 157.75M | 205.75M | 12.36M | 9.54M | 20.79M | 15.75M | 13.00M | 20.38M | 6.14M | 0 | 0 |
| Net Income | (80.94M) | (29.73M) | 9.35M | (203.67M) | (72.15M) | (25.99M) | (21.79M) | (10.90M) | (24.60M) | (19.45M) | (32.83M) | (10.55M) |
| EPS | -3.00 | -1.12 | 0.35 | -7.74 | -3.55 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 |
| Total Assets | 344.07M | 429.40M | 450.39M | 392.81M | 476.46M | 82.14M | 44.20M | 52.02M | 51.57M | 71.68M | 22.32M | 50.32M |
| Total Debt | 28.55M | 30.22M | 94.75M | 69.15M | 20.75M | 20.67M | 9.91M | 0 | 133,000 | 0 | 0 | 0 |
| Cash & Equivalents | 237.03M | 292.00M | 391.88M | 370.49M | 462.89M | 71.35M | 36.71M | 24.96M | 2.30M | 16.66M | 2.18M | 22.09M |
| Operating Cash Flow | (59.75M) | (18.10M) | 31.99M | (135.04M) | (42.86M) | (6.45M) | (20.76M) | (460,000) | (19.24M) | (18.15M) | (28.33M) | (7.35M) |
| Free Cash Flow | (60.40M) | (21.00M) | 24.27M | (138.45M) | (44.60M) | (7.26M) | (22.24M) | (711,000) | (19.32M) | (18.33M) | (28.41M) | (7.39M) |
| FCF per Share | -2.24 | -0.79 | 0.92 | -5.26 | -2.20 | -0.60 | -2.21 | -0.23 | -4.91 | -5.93 | -14.54 | -5.08 |
| Book Value | 240.98M | 278.51M | 270.31M | 228.21M | 396.55M | 25.79M | 13.64M | 33.79M | 47.23M | 69.33M | 19.94M | 48.69M |
| Cash & ST Investments | 237.03M | 292.00M | 391.88M | 370.49M | 462.89M | 71.35M | 36.71M | 48.57M | 50.24M | 50.68M | 21.70M | 50.10M |
| ROC Equity | -0.34 | -0.11 | 0.03 | -0.89 | -0.18 | -1.01 | -1.60 | -0.32 | -0.52 | -0.28 | -1.65 | -0.22 |